Use of intravenous magnesium sulfate among patients with acute myocardial infarction in China from 2001 to 2015: China PEACE-Retrospective AMI Study.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.

In 2001, Chinese guidelines for the care of acute myocardial infarction (AMI) included a new recommendation against the routine use of magnesium.

Who Took Part

According to the abstract, 28,208 patients were involved.

PubMed indexes the participants as middle-aged adults and older adults, both men and women.

In an observational study (China PEACE-Retrospective Study) of AMI care, the researchers used a two-stage, random sampling strategy to create a nationally representative sample of 28 208 patients with AMI at 162 Chinese hospitals in 2001, 2006, 2011 and 2015.

How the Study Was Run

The main outcome is use of intravenous magnesium sulfate over time.

What Was Measured

Topics PubMed links to this paper include Administration, Intravenous, China, Heart Arrest, Magnesium Sulfate and Myocardial Infarction.

The authors tagged it with the keywords acute myocardial infarction and quality of healthcare.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 28,208 patients.

With several hundred people or more, it is a fairly large study for this kind of research.

Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2020 (BMJ open), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.